Align Technology | ALGN - Vertriebs- Und Verwaltungskosten

Aktienkurs
189.61
Täglich Wechseln
-1.06 -0.56%
Monatlich
5.18%
Jährlich
3.41%
Q2 Prognose
185.55




Vertriebs- Und Verwaltungskosten Veränderung Datum
3M USD 744M 221M 2026-03
Align Technology USD 441.68M 23.88M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Bruker USD 247.2M 4.7M 2025-12
Cardinal Health USD 1.5B 43M 2025-12
Charles River Laboratories USD 196.14M 18.55M 2025-12
Cooper Companies USD 373.1M 46.1M 2025-12
Danaher USD 1.86B 166M 2026-03
Dentsply International USD 383M 28M 2025-12
Dexcom USD 299.9M 31.5M 2025-12
Henry Schein USD 808M 48M 2025-12
Idexx Laboratories USD 275.68M 10.58M 2025-12
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 156.45M 12.6M 2025-12
IQVIA Holdings USD 468M 46M 2025-12
Masimo USD 128M 11.6M 2025-12
McKesson USD 2.03B 44M 2025-12
Mettler Toledo International USD 259.83M 11.43M 2025-12
Revvity USD 251.73M 9.82M 2025-12
Solventum Corp USD 759M 15M 2025-12
Stryker USD 2.14B 150M 2025-12
Teleflex USD 222.37M 59.4M 2025-12
Thermo Fisher Scientific USD 1.8B 179M 2026-03
Veeva Systems USD 125.08M 3.11M 2025-12
Waters USD 240.01M 25.78M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12
Zoetis USD 619M 40M 2025-12